La vendita allo scoperto per Apogee Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Apogee Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Apogee Therapeutics (NASDAQ:APGE) Azioni, Report sulle vendite allo scoperto

APOGEE THERAPEUTICS INC

Apogee Therapeutics

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics Inc

News

Analyst Ratings

Trading Ideas

CASY

Live On CNBC, Jim Lebenthal Announces Sold Caseys General Stores

Shares of Circle Internet Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), the issuer of the USDC stablecoin, continued their meteoric rise on Monday, hitting new highs in another volatile session. The rally extends a powerful run since the company's <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45821941/circle-crcl-stock-surges-after-successful-ipo-debut-whats-going-on">blockbuster IPO on June 5</a>.
What To Know: Circle Internet Group priced its IPO at $31, but the stock, which has captivated investors, opened for trading at $69 and closed its first day on public markets at $83.23 and has continued to see strong momentum.
The surge is being fueled by significant institutional interest, highlighted by a large purchase from Cathie Wood&#8217;s ARK Invest shortly after the debut. Wood called the IPO an &#8220;amazing debut,&#8221; citing the <a href="https://www.benzinga.com/markets/ipos/25/06/45819104/cathie-wood-calls-circles-ipo-an-amazing-debut">growing role</a> of stablecoins like USDC in creating demand for U.S. dollars.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45939432/bitcoins-current-cycle-sees-a-656-surge-matching-market-maturation-pace">Bitcoin&#8217;s Current Cycle Sees A 656% Surge, Matching Market Maturation Pace</a>
Circle is a pivotal player in the <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45821941/circle-crcl-stock-surges-after-successful-ipo-debut-whats-going-on">digital finance ecosystem</a>, holding over $22 billion in U.S. Treasuries to back its stablecoin, making it one of the largest non-sovereign holders of U.S. debt. The company&#8217;s successful IPO marks a key milestone in the integration of stablecoins into global finance.
CRCL Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CRCL shares were trading up 15.4% at $154.82 at the time of publication Monday. The stock set a new 52-week high of $165.60 on Monday before pulling back. Session trading volume was above 29 million shares midday Monday, compared to its average of approximately 36 million.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45952440/lockheed-martin-lmt-stock-is-falling-monday-whats-going-on">Lockheed Martin Stock Is Falling Monday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy CRCL Stock</h2>
By now you're likely curious about how to participate in the market for Circle Internet Group &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

Movers

CRCL

Circle Internet Group (CRCL) Stock Hits New Highs: What's Going On?

WIIM

EVEX

Eve Holding shares are trading higher after the company announced it secured a $250 million deal with Revo and OHI to deliver up to 50 eVTOL aircraft and aftermarket services.

JOET

Live On CNBC, Joe Terranova Announces Bought Enbridge

iShares MSCI Israel Capped Investable Market Index Fund

Live On CNBC, Joe Terranova Announces Bought iShares Inc iShares MSCI Israel ETF; Bought Suncor Energy

Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares are trading higher Monday following a positive update from Piper Sandler. There are also unconfirmed rumors that the company scored a &#8220;GPU win&#8221; with <a href="https://www.benzinga.com/topic/aws">Amazon Web Services</a>. 
What&#8217;s Going On: Piper Sandler analyst Harsh Kumar maintained AMD with an <a href="https://www.benzinga.com/analyst-stock-ratings">Overweight rating</a> and raised its price target from $125 to $140 following the chipmaker&#8217;s pre-quarter close call.
Kumar highlighted product launches at AMD&#8217;s &#8220;Advancing AI&#8221; event last week, noting that the <a href="https://www.benzinga.com/markets/tech/25/06/45919591/amd-challenges-nvidias-ai-dominance-with-new-helios-server-as-openai-ceo-sam-altman-confirms-chatgpt-will-use-lisa-su-led-tech-giants-latest-chips-future-of-ai-is-not-going-to-be-built-b">Helios rack announcement</a> is &#8220;pivotal&#8221; for AMD Instinct growth moving forward. 
The Piper Sandler analyst is also optimistic that the company&#8217;s GPU business is trending in the right direction and should see a &#8220;snapback&#8221; in the fourth quarter after it gets past China-related charges. 
&#8220;We know that AMD's AI business is expected to inflect upward starting 3Q25 and that should offset some of these charges. We are showing growth in our model for the AI business starting Sept 25 quarter,&#8221; the analyst said in a new note to clients.
Kumar also noted that AMD and Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) appear to be engaged in a strong relationship, with Amazon being a customer at multiple levels. 
&#8220;The relationship spans CPUs + GPUs and Amazon is likely to announce the relationship at its own discretion. There was some speculation about this in the investor community,&#8221; the Piper Sandler analyst said. 
The potential expanded relationship with Amazon appears to be the main driver of the strong surge in AMD shares on Monday. CNBC&#8217;s David Faber reported on &#8220;Squawk On The Street&#8221; that the unusual momentum in shares appears to be fueled by an unconfirmed rumor about a GPU deal between the two companies. 
&#8220;I am hearing some talk though that involves perhaps a GPU win for AMD from AWS,&#8221; Faber said Monday morning on the show. 
Amazon <a href="https://www.benzinga.com/markets/25/05/45298390/amazon-acquires-84-4-million-stake-in-amd-amid-ai-chip-expansion-export-controls">disclosed</a> in a regulatory filing last month that it acquired an $84.4 million stake in AMD after the chipmaker acquired server manufacturer ZT Group International,&nbsp;which Amazon held a stake in. In connection with the takeover deal, AMD issued shares to ZT Group shareholders, including Amazon. 
AMD Price Action: <a href="http://benzinga.com/quote/AMD">AMD shares</a> were up 9.44% at $127.04 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45952716/stock-market-today-sp500-rises-iran-israel-nasdaq-near-record-highs">Wall Street Roars Back As Iran Signals De-Escalation: Nasdaq 100 Nears All-Time High</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/06/45953943/taiwan-semiconductor-eyes-rollout-of-2nm-advanced-tech-chips-this-year">Taiwan Semiconductor Eyes Rollout Of 2nm Advanced Tech Chips This Year</a></li>
</ul>
Photo: courtesy of AMD.

AMZN

AMD Stock Is Soaring Monday: What's Going On?

<a href="https://www.benzinga.com/topic/luxury-goods">Luxury accessories giant</a> Tapestry Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) is getting a clear growth split between its key brands, according to JPMorgan analyst Matthew R. Boss.
The spotlight firmly shines on Coach, which is staging a notable comeback with a projected 32% upside for the overall company stock by year-end, per Boss&#8217; projections. Meanwhile, Kate Spade is lagging, creating a tale of two brand trajectories under the same roof.
Read Also: <a href="https://www.benzinga.com/insights/news/25/06/45849532/heres-how-much-100-invested-in-tapestry-5-years-ago-would-be-worth-today">Here&#8217;s How Much $100 Invested In Tapestry 5 Years Ago Would Be Worth Today</a>
<h1 class="wp-block-heading">Coach's Growth Engine: Pricing Power Meets Younger Buyer Momentum</h1>
Coach is driving the bulk of Tapestry's growth story. JPMorgan's fieldwork highlights a more balanced multi-year revenue growth fueled by both average unit retail (AUR) price hikes and sustainable unit sales growth, says Boss. 
Coach's handbag prices are climbing steadily, with management pointing to improved full-price selling and fresh, innovative product lines as key drivers. Although handbag unit sales had declined in recent years, new customer acquisition — especially from Gen-Z and Millennials — is turning the tide.
These younger buyers are not only spending more per purchase but are also returning frequently and influencing older customers to re-engage with the brand. Add in strong momentum in footwear and international store expansions, and Coach's growth runway looks durable and diversified.
<h1 class="wp-block-heading">Kate Spade Falters As Coach Shoulders The Growth Load</h1>
Kate Spade, on the other hand, has seen revenue declines this year, with management taking a cautious stance amid uncertain macroeconomic conditions. The brand's fourth quarter guidance suggests a drop in sales, contrasting sharply with Coach's low-double-digit growth expectations. 
While Kate Spade remains an important part of Tapestry's portfolio, it currently plays a supporting role in the group's financial outlook.
Tapestry's upside potential is largely driven by Coach's revival, supported by pricing power, customer rejuvenation and expanding categories. With a $104 price target, investors have reason to watch closely as Coach leads the charge while Kate Spade works through challenges.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/25/04/44656550/grant-cardone-roasts-luxury-items-and-recommends-real-estate-instead-birkin-bags-are-not-investments">Grant Cardone Roasts Luxury Items and Recommends Real Estate Instead: &#8216;Birkin Bags Are Not Investments&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Coach Bags A 32% Upside, But Kate Spade Lags Behind In Tapestry's Playbook

ADBE

Live On CNBC, Jim Lebenthal Announces Bought More Adobe

Live On CNBC, Karen Firestone Announces Sold Adobe

Advanced Micro Devices shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $125 to $140.

EMCOR Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) has outperformed the market over the past 15 years by 10.19% on an annualized basis producing an average annual return of 22.23%. Currently, EMCOR Group has a market capitalization of $21.92 billion. 
Buying $1000 In EME: If an investor had bought $1000 of EME stock 15 years ago, it would be worth $19,903.03 today based on a price of $486.43 for EME at the time of writing.
<h3>EMCOR Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750090515_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In EMCOR Group 15 Years Ago Would Be Worth This Much Today

Shares of Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) are climbing on Monday, continuing last week&#8217;s rally. The data analytics firm is benefiting from a confluence of positive news that has bolstered investor confidence, sending the stock to <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45910359/palantir-technologies-pltr-pulls-back-after-hitting-all-time-high-whats-going-on">another new all-time high</a> Monday.
What To Know: Palantir last week announced a partnership with specialty paper manufacturer Fedrigoni to <a href="https://www.benzinga.com/markets/tech/25/06/45860820/fedrigoni-taps-palantir-partner-to-boost-demand-responsiveness-dynamics-with-ai">advance</a> its digital transformation using Palantir's AI platform. This news, coupled with last month&#8217;s strong <a href="https://www.benzinga.com/news/earnings/25/05/45208000/palantir-q1-earnings-revenue-beat-eps-in-line-customer-count-up-39-company-raises-guidance-citing-surging-and-ferocious-growth">earnings report</a> showing a 39% year-over-year increase in its customer count and raised full-year guidance, are among several recent catalysts helping propel the stock to new highs.
Palantir also continues to catch the eye of Wall Street, with Bank of America strategist Michael Hartnett spotlighting the company in his <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45838431/trumps-policies-power-bro-billionaires-while-main-street-stocks-lag-bofas-hartnett-says">&#8216;bro billionaire&#8217;</a> basket of elite tech performers.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45949030/roku-stock-surges-on-new-integration-with-amazon-details-of-the-deal">Roku Stock Surges On New Integration With Amazon: Details Of The Deal</a>
Further tailwinds have emerged as <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45933800/palantir-shares-are-up-today-whats-going-on">geopolitical tensions</a> rose last week, with Israel-Iran tensions increasing interest in defense-related equities. Palantir, a key software provider for U.S. military and intelligence agencies, is often seen as a beneficiary of increased government spending on security. 
Adding to the momentum, U.S. Immigration and Customs Enforcement has also <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45933800/palantir-shares-are-up-today-whats-going-on">announced</a> its intent to expand its use of blockchain surveillance tools, a sector where Palantir is an established vendor.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Palantir was trading at $142.22, up 3.52% on Monday. Trading volume was active, with over 28 million shares exchanged early Monday. The stock&#8217;s 52-week range is $21.23 to $144.86.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45948701/archer-aviation-stock-rises-on-deal-to-deploy-midnight-aircraft-in-indonesia">Archer Aviation Stock Rises On Deal To Deploy Midnight Aircraft In Indonesia</a>
<h2 class="wp-block-heading">How To Buy PLTR Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Palantir Technologies&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

PLTR

Palantir Technologies (PLTR) Stock Hits A New All-Time High: What's Going On?

<a href="https://www.bloomberg.com/news/articles/2025-06-16/russia-says-us-canceled-planned-meeting-on-bilateral-relations">https://www.bloomberg.com/news/articles/2025-06-16/russia-says-us-canceled-planned-meeting-on-bilateral-relations</a>

General

'Russia Says US Canceled Planned Meeting on Bilateral Relations'- Bloomberg

Imax Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) seems to be "on a roll," given that it has among the strongest film pipelines in recent years and has formed closer relationships with studios and top directors, according to Rosenblatt Securities.
The Imax Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62cd3de0fad12200016941e4/steve-frankel">Analyst Steve Frankel</a> reaffirmed a Buy rating and price target of $35.
The Imax Thesis: Frankel said in the note that the company has "a long runway of growth," given that it is gaining market share due to rising demand for superior experiences. Studios and filmmakers are scheduling their release dates to secure IMAX screens, and exhibitors wish to increase their IMAX footprint.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
"A record number of Filmed for IMAX titles is driving over-indexing, setting the stage for the company to outperform our/Street expectations," he further wrote.
There is high visibility into the company's performance, not just for 2025, but for several years to come, the analyst stated. In fact, 2026 could be "even better than 2025, beginning with Avatar: Fire and Ash," he further said.
Imax is likely to generate "at least mid-single digit growth for the foreseeable future," while incremental box office gains go directly to improve profits, "given the fixed cost nature of the business," Frankel wrote.
IMAX Price Action: Shares of Imax had declined by 0.87% to $28.63 at the time of publication on Monday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/06/45946624/canaan-stock-a-deep-dive-into-analyst-perspectives-8-ratings">Tom Cruise&#8217;s &#8216;Mission: Impossible – The Final Reckoning&#8217; Smashes China Box Office With $25.6 Million Opening, Sets IMAX Record For Hollywood Films In 2025</a></li>
</ul>
Photo: Shutterstock

Reiteration

IMAX

Imax Set For Years Of Growth, But A Blockbuster Sequel Could Ignite 2026

<a href="https://cloud.google.com/compute/docs/release-notes" title="https://cloud.google.com/compute/docs/release-notes">https://cloud.google.com/compute/docs/release-notes</a>

GOOG

GOOGL

Google Announces General Availability Of Next-Generation C4D Virtual Machine Family

Truist Securities analyst David Smith maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Buy and raises the price target from $97 to $100.

Price Target

SCHW

Truist Securities Maintains Buy on Charles Schwab, Raises Price Target to $100

As institutions flock into spot Bitcoin ETFs, long-term investors must make a critical choice: Invest in ETF's or take matters into their own hands using a private physical wallet?
Bitcoin ETFs have opened the floodgates of institutional funds, with billions flowing in through products by BlackRock, Fidelity, and other financial giants. But trading volumes are rising and Bitcoin is trading at cycle highs, and one essential question remains: Is it best to hold an ETF, or do you go for custody in your own hands?
By 2025, the Bitcoin market is expanding exponentially. ETFs have provided ease of exposure for retail investors, but ETF's have also introduce regulatory, custodian, and counterparty risk. Bitcoin&#8217;s freedom ethos and independence are drawing others to cold storage and self-custody options like Ledger, Trezor, and Foundation Devices.
Institutional Momentum: The Case for Bitcoin ETFs
The SEC&#8217;s greenlighting of spot Bitcoin ETFs in early 2024 was a watershed. Spot ETFs such as iShares Bitcoin Trust (IBIT) and Fidelity Wise Origin Bitcoin Fund (FBTC) had tens of billions of assets under management within months.
Why ETFs are appealing:
• Ease: Not having to deal with keys, wallets, or blockchain validations.
• Regulation: Supported by top companies, ETFs are under tight compliance requirements.
• Liquidity: Easy to buy and sell through brokerage accounts or retirement savings.
ETFs have provided an easy way for pension funds, and institutions to take a stake without venturing onto crypto-native platforms. For a lot of them, especially those constrained by mandates or fiduciary regulations, this is the only compliant path. But there&#8217;s a catch.
Self-Custody: The Road of Sovereignty
The second, increasingly popular option for privacy-oriented and long-term investors is physical custody. This entails keeping Bitcoin in a non-custodial wallet, with the user keeping their private keys.
Why self-custody matters:
• Sovereignty: You own and maintain control of your Bitcoin.
• Less counterparty risk: No bank, broker, or custodian dependence.
• Privacy: No KYC or government-related exposure if acquired through decentralized sources.
Events like the FTX debacle, the ByBit hack in 2025, bank failures, and global CBDC launches have rekindled interest in cold storage. Hardware wallets &nbsp;and decentralized DEX swaps like THORChain allow users to remain off-grid, if they so choose.
What Smart Money Is Doing
Institutional investors are indeed rushing into ETFs—but high-net-worth investors and crypto-native funds are hedging. Some are employing ETFs as a source of liquidity and cold wallets for their core long positions.
Example strategies:
• 70/30 strategy: Self-custody for strategic reserves and ETF use for swing trades and tax efficiency in short-term.
• Estate planning: Multi-signature wallets are being used by high-net-worth investors for generational asset transfer.
• Ledger custody + DEX trading: Traders avoid centralized exchanges and maintain BTC held offline, trading through privacy-mindful tools.
The ETF final verdict
Whether your portfolio is $1,000 or $10 million, how you employ your custody of Bitcoin will depend on your needs and security appetite. ETFs offer convenience, accessibility, and compliance, but self-custody offers sovereignty, privacy, and durability.
For me the decision is a no brainer, and I self custody using a Ledger private cold wallet. Security is my number 1 priority. The most successful investors in 2025 are examining and utilizing both instruments tactically, balancing access with autonomy.
 Disclosure: The author has a BTC investment.
&#x2A;&#x2A;
Our wallet guide at <a href="https://cryptoflowzone.com/top-crypto-wallets">https://cryptoflowzone.com/top-crypto-wallets</a>  can equip investors with information to make their own decision.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Opinion

Personal Finance

ETFs

Bitcoin ETFs Vs. Physical Custody: Where Smart Money Is Heading In 2025

Truist Securities analyst Richard Newitter initiates coverage on Tandem Diabetes Care (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) with a Hold rating and announces Price Target of $24.

Initiation

TNDM

Truist Securities Initiates Coverage On Tandem Diabetes Care with Hold Rating, Announces Price Target of $24

Truist Securities analyst Richard Newitter initiates coverage on DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) with a Buy rating and announces Price Target of $102.

DXCM

Truist Securities Initiates Coverage On DexCom with Buy Rating, Announces Price Target of $102

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares are trading higher Monday after the company announced that WhatsApp will show ads and offer paid subscriptions <a href="https://www.benzinga.com/topic/whatsapp">for the first time</a>.
What Happened: Meta is set to begin displaying ads inside of its cross-platform messaging application WhatsApp, opening the company up to additional revenue.
The Facebook parent company, which has seen ads success on other platforms, will introduce ads in the &#8220;Updates&#8221; section of WhatsApp, which gets 1.5 billion visitors each day.
&#8220;We've been talking for years about how to build a business on WhatsApp in a way that doesn't interrupt personal chats, and we believe the Updates tab is the right place to introduce that,&#8221; Meta <a href="https://about.fb.com/news/2025/06/helping-you-find-more-channels-businesses-on-whatsapp/">said</a> on Monday.
Advertisers will be able to pay fees to promote ads on their WhatApp Channels, which will make ads stand out in the Updates tab of the platform. Advertisers will also be able to sell subscriptions. Meta plans to eventually take a 10% cut of subscription sales, according to <a href="https://www.bloomberg.com/news/articles/2025-06-16/whatsapp-to-show-ads-offer-paid-subscriptions-for-first-time?srnd=phx-technology">Bloomberg</a>. 
The report indicates that the new ads initiative is aimed at expanding revenue streams in order to help fund the company&#8217;s AI investments, an area Meta continues to spend heavily in, including with its <a href="https://www.benzinga.com/news/topics/25/06/45939001/meta-in-talks-to-invest-over-10b-in-scale-ai-possibly-the-biggest-private-ai-deal-this-year">recent stake</a> in Scale AI. 
Ads on WhatsApp will not be nearly as targeted as Facebook and Instagram ads, which often use personal information and browsing history to deliver relevant ads. WhatApp ads are expected to be more broad and focus on a user&#8217;s location and Channels they follow on the app.
Ads are expected to start appearing on the WhatsApp platform on Monday for some users. The company said it will be rolling out ads slowly over the next several months.
Meta said at the end of April that it generated $41.39 billion in total advertising revenue during the <a href="https://www.benzinga.com/news/earnings/25/04/45117948/meta-q1-earnings-eps-beat-revenue-up-16-ai-approaches-1-billion-monthly-actives-capital-expenditures-forecast-raised">first quarter</a>, up from $35.65 billion in the first quarter of 2024. Ad impressions across its family of apps increased by 5% year-over-year and average price per ad jumped 10%.
META Price Action: <a href="http://benzinga.com/quote/META">Meta shares</a> were up 2.51% at $700.03 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45949332/broadcom-marvell-ride-the-30b-asic-wave-but-only-one-looks-ready-for-takeoff">Broadcom, Marvell Ride The $30B ASIC Wave – But Only One Looks Ready For Takeoff</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45950641/accenture-to-rally-more-than-13-here-are-10-top-analyst-forecasts-for-monday">Accenture To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Monday</a></li>
</ul>
Photo: Worawee Meepian/Shutterstock.

Social Media

Meta Stock Is Moving Higher Monday: What's Going On?

Press Releases

Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference

Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics to Participate in Upcoming March Investor Conferences

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)

Earnings

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results

Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

Health Care

Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma

Comments

Apogee Therapeutics

Vendite allo scoperto

Apogee Therapeutics (NASDAQ:APGE) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO